[EN] INHIBITORS OF ACETYL-COA CARBOXYLASE<br/>[FR] INHIBITEURS DE L'ACÉTYL-COA CARBOXYLASE
申请人:FOREST LAB HOLDINGS LTD
公开号:WO2010127208A1
公开(公告)日:2010-11-04
The present invention relates to compounds that act as acetyl-CoA carboxylase (ACC) inhibitors. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.
This invention relates to novel fluorinated ethers, useful as insecticides and acaricides, to processes and intermediates for their preparation, to insecticidal and acaricidal compositions thereof and to methods of combating and controlling insect and acarine pests therewith.
A new class of polymeric hole-transportmaterials (HTMs) was explored, featuring fluorine-substituted pyrene and specific Pb−Se secondary interactions. Perovskitesolarcells (PSCs) using PE10 as dopant-free HTM, afforded an excellent PCE of 22.3 %, positioning it among the best PSCs based on dopant-free HTMs.
intermediates of formula:-
wherein Q is selected from carbon bearing a hydrogen atom and nitrogen; Z represents one or more substituents selected from fluoro, benzyl, phenoxy, chlorophenoxy, fluorophenoxy and bromophenoxy, and R4 is selected from hydroxy, bromo, chloro and iodo, or R4 is selected from a group of formula:-- P(R)3
and a group of formula:-
wherein R represents alkyl or aryl. The intermediates of the invention are useful in the preparation of insecticidal compoumds.
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
申请人:Agouron Pharmaceuticals, Inc.
公开号:US20040023958A1
公开(公告)日:2004-02-05
Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.
1
式 I 的化合物是丙型肝炎病毒(HCV)RNA 依赖性 RNA 聚合酶(RdRp)抑制剂,可用于丙型肝炎病毒感染者的治疗和预防。
1